Detection and phenotyping of circulating tumor cells in high-risk localized prostate cancer

Detection and phenotyping of circulating tumor cells in high-risk localized prostate cancer

Publication: Clin Genitourin Cancer

Background: In this study, we aimed to determine the feasibility of identifying CTCs in patients with HRLPC, using a modified isolation procedure using the CellSearch...

Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide

Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide

Publication: Neuropharmacology
Software: ADMET Predictor®

This study aimed at evaluating the effects of eslicarbazepine, carbamazepine (CBZ), oxcarbazepine (OXC) and lacosamide (LCM) on the fast and slow inactivated states of voltage-gated sodium channels (VGSC).

Computational Predictions of Glass-Forming Ability and Crystallization Tendency of Drug Molecules

Computational Predictions of Glass-Forming Ability and Crystallization Tendency of Drug Molecules

Publication: Mol Pharm
Software: ADMET Predictor®

Amorphization is an attractive formulation technique for drugs suffering from poor aqueous solubility as a result of their high lattice energy.

RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma

RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma

Publication: Mol Cancer Res

Sarcomatoid metastatic renal cell carcinoma (mRCC) is associated with a poor prognosis, and the biology of the disease has been inadequately characterized.

Physiologically Based Absorption Modelling to Predict the Impact of Drug Properties on Pharmacokinetics of Bitopertin

Physiologically Based Absorption Modelling to Predict the Impact of Drug Properties on Pharmacokinetics of Bitopertin

Publication: AAPS J
Software: GastroPlus®

Bitopertin (RG1678) is a glycine reuptake inhibitor in phase 3 trials for treatment of schizophrenia. Its clinical oral pharmacokinetics is sensitive to changes in drug substance particle size and dosage form.

Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists

Discovery of furan-2-carbohydrazides as orally active glucagon receptor antagonists

Publication: Bioorg Med Chem Lett.
Software: ADMET Predictor®

Furan-2-carbohydrazides were found as orally active glucagon receptor antagonists. Starting from the hit compound 5, we successfully determined the structure activity relationships of a series...

In Silico Prediction of Major Drug Clearance Pathways by Support Vector Machines with Feature-Selected Descriptors

In Silico Prediction of Major Drug Clearance Pathways by Support Vector Machines with Feature-Selected Descriptors

Publication: Drug Metab Dispos
Software: ADMET Predictor®

We have previously established an in silico classification method ("CPathPred") to predict the major clearance pathways of drugs based on an empirical decision with only four physicochemical...

Dissolution testing combined with computer simulation technology to evaluate the bioequivalence of domestic amoxicillin capsule

Dissolution testing combined with computer simulation technology to evaluate the bioequivalence of domestic amoxicillin capsule

Authors: Pan RX, Gao Y, Chen WL, Li YL, Hu CQ
Publication: Yao Xue Xue Bao
Software: GastroPlus®

Re-evaluation of bioequivalence of generic drugs is one of the key research focus currently. As a means to ensure consistency of the therapeutic effectiveness of drug products, clinical bioequivalence...

Intestinal transport of TRH analogs through PepT1: the role of in silico and in vitro modeling

Intestinal transport of TRH analogs through PepT1: the role of in silico and in vitro modeling

Publication: J Mol Recognit
Software: GastroPlus®

The present study involves molecular docking, molecular dynamics (MD) simulation studies, and Caco-2 cell monolayer permeability assay to investigate the effect of structural modifications on...

Enhanced Solubility and Oral Bioavailability of y-Tocotrienol Using a Self-Emulsifying Drug Delivery System (SEDDS)

Enhanced Solubility and Oral Bioavailability of y-Tocotrienol Using a Self-Emulsifying Drug Delivery System (SEDDS)

Publication: Lipids
Software: GastroPlus®

The aim of this study was to evaluate the in vitro and in vivo performance of γ-tocotrienol (γ-T3) incorporated in a self-emulsifying drugdelivery system (SEDDS)...

Design of a General-Purpose European Compound Screening Library for EU-OPENSCREEN

Design of a General-Purpose European Compound Screening Library for EU-OPENSCREEN

Publication: ChemMedChem
Software: MedChem Studio™

This work describes a collaborative effort to define and apply a protocol for the rational selection of a general-purpose screening library, to be used by the screening platforms affiliated with the EU-OPENSCREEN initiative.

Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid-Mediated DILI

Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid-Mediated DILI

Publication: CPT Pharmacometrics Syst Pharmacol
Software: DILIsym®
Division: DILIsym Services

Bile salt export pump (BSEP) inhibition has been proposed to be an important mechanism for drug-induced liver injury (DILI). 

Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivir

Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivir

Publication: Eur J Pharm Sci
Software: ADMET Predictor®

Alisporivir is a novel cyclophilin-binding molecule with potent anti-hepatitis C virus (HCV) activity. In vitro data from human liver microsomes suggest that alisporivir is a substrate and a time-dependent inhibitor (TDI) of CYP3A4.

Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development

Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development

Publication: J Pharmacol Toxicol Methods
Software: GastroPlus®

Cardiovascular toxicity is a significant cause of candidate failure in drug development. Pharmacokinetic/pharmacodynamic (PK/PD) modeling may reduce attrition by improving the understanding...